{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:06:57Z","timestamp":1784804817667,"version":"3.55.0"},"reference-count":77,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Cardio-renal syndrome (CRS) is a complex condition involving bidirectional dysfunction of the heart and kidneys, in which the failure of one organ exacerbates failure in the other. Traditional pharmacologic treatments are often insufficient to manage the hemodynamic and neurohormonal abnormalities underlying CRS, especially in cases resistant to standard therapies. Device-based therapies have emerged as a promising adjunct or alternative approach, offering targeted intervention to relieve congestion, improve renal perfusion, and modulate hemodynamics. This study aimed to evaluate the efficacy and safety of various device-based therapies in CRS management, utilizing DRI2P2S classification to categorize interventions as dilators, reducers, interstitial modulators, pullers, pushers, and shifters. Methods: A comprehensive analysis of clinical trial data and observational studies involving device-based therapies in patients with CRS was conducted, with a focus on hemodynamic endpoints, renal and cardiac function, symptom relief, and adverse events. Devices included in the analysis were splanchnic denervation systems (dilators), devices for central and pulmonary pressure reduction (reducers), and systems targeting interstitial fluid (fluid shifters), among others. A systematic literature review from 2004 to 2024 was performed using databases including PubMed, Embase, and ClinicalTrials.gov, following PRISMA guidelines for study selection. Data were extracted on patient demographics, device type, trial design, outcomes, and follow-up duration. Results: Device-based therapies demonstrated varying levels of efficacy in CRS, with significant improvements observed in specific parameters. Notable results were a reduction in central venous pressure and improved diuretic responsiveness in acute CRS cases, while also stabilizing or improving renal function. Other relevant endpoints were fewer heart failure hospitalizations and a reduction in renal adverse events, reduced tissue congestion and improved quality of life scores. However, some devices presented challenges, including procedure-related complications and a learning curve for optimal device implantation. Conclusions: Device-based therapies offer a valuable addition to the CRS treatment paradigm, particularly in cases unresponsive to conventional diuretics and other pharmacologic measures. Each of them addresses specific pathophysiological components of CRS and shows promise in improving clinical outcomes. Nevertheless, further large-scale, long-term trials with comprehensive endpoints are needed to establish these therapies\u2019 roles in standard care and to optimize patient selection criteria. Enhanced understanding of device mechanisms and refinement of trial endpoints will be key to maximizing the impact of these therapies on quality of life and clinical outcomes for CRS patients.<\/jats:p>","DOI":"10.3390\/jcm13247814","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T10:58:55Z","timestamp":1734951535000},"page":"7814","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardio-Renal Syndrome: Latest Developments in Device-Based Therapy"],"prefix":"10.3390","volume":"13","author":[{"given":"Vlad","family":"Meche","sequence":"first","affiliation":[{"name":"Doctoral School, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 3000041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-7182","authenticated-orcid":false,"given":"Nilima Rajpal","family":"Kundnani","sequence":"additional","affiliation":[{"name":"University Clinic of Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, Department VI\u2014Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 3000041 Timisoara, Romania"},{"name":"Research Centre of Timisoara Institute of Cardiovascular Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 3000041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-0054","authenticated-orcid":false,"given":"Abhinav","family":"Sharma","sequence":"additional","affiliation":[{"name":"University Clinic of Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, Department VI\u2014Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 3000041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia-Maria","family":"C\u0103p\u0103straru","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 3000041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0489-246X","authenticated-orcid":false,"given":"Daciana","family":"Nistor","sequence":"additional","affiliation":[{"name":"Department of Functional Sciences, Physiology, Center of Immuno-Physiology and Biotechnologies (CIFBIOTEH), \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Centre for Gene and Cellular Therapies in Cancer, 300723 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1938-1443","authenticated-orcid":false,"given":"Cristian Andrei","family":"Sarau","sequence":"additional","affiliation":[{"name":"Department of Medical Semiology I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timi\u015foara, Romania"},{"name":"Municipality University Emergency Hospital, 300254 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5204-6954","authenticated-orcid":false,"given":"Laura","family":"Gaita","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"\u201cPius Br\u00eenzeu\u201d Emergency County Hospital, 300723 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/ndt\/gfq180","article-title":"Prevention of cardio-renal syndromes: Workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"McCullough","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/hrt.2009.166256","article-title":"Cardiorenal syndrome in decompensated heart failure","volume":"96","author":"Tang","year":"2010","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000313718","article-title":"Cardiorenal syndromes: Definition and classification","volume":"164","author":"Ronco","year":"2010","journal-title":"Contrib. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMe048211","article-title":"Chronic kidney disease predicts cardiovascular disease","volume":"351","author":"Hostetter","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"de Oliveira Cardoso, C., Elgalad, A., Li, K., and Perin, E.C. (2022). Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI(2)P(2)S classification. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.962839"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e008934","DOI":"10.1161\/CIRCHEARTFAILURE.121.008934","article-title":"Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study","volume":"15","author":"Kapur","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/clc.23286","article-title":"Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial","volume":"43","author":"Cunningham","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_9","first-page":"101509","article-title":"The role of urine sodium in acutely decompensated heart failure","volume":"55","author":"Hoen","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ganes, A., Davis, J.A., Virtanen, J.K., Voutilainen, A., Tuomainen, T.P., Atherton, J.J., Amerena, J., Driscoll, A., Hare, D.L., and Wittert, G. (2022). Urinary sodium concentration predicts time to major adverse coronary events and all-cause mortality in men with heart failure over a 28-33-year period: A prospective cohort study. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02830-3"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/ejhf.2587","article-title":"Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): Baseline characteristics","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: The CLOROTIC trial","volume":"44","author":"Casado","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ejhf.3253","article-title":"Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial","volume":"26","author":"Vaduganathan","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mody, R., Nee Sheth, A.B., Dash, D., Mody, B., Agrawal, A., Monga, I.S., Rastogi, L., and Munjal, A. (2024). Device therapies for heart failure with reduced ejection fraction: A new era. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1388232"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","article-title":"Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial","volume":"46","author":"Bart","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","article-title":"Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: Results from UNLOAD","volume":"16","author":"Costanzo","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: Systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wilson Tang, W.H., and Wilfried Mullens, F.H.V. (2020). Cardiorenal Syndrome in Heart Failure, Springer.","DOI":"10.1007\/978-3-030-21033-5"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ccd.28326","article-title":"First-in-human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failure","volume":"93","author":"Kapur","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.118.035260","article-title":"Splanchnic Nerve Block for Acute Heart Failure","volume":"138","author":"Fudim","year":"2018","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.2196","article-title":"Splanchnic nerve modulation in heart failure: Mechanistic overview, initial clinical experience, and safety considerations","volume":"23","author":"Fudim","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e009340","DOI":"10.1161\/CIRCHEARTFAILURE.121.009340","article-title":"Targeting Preload in Heart Failure: Splanchnic Nerve Blockade and Beyond","volume":"15","author":"Fudim","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jchf.2020.04.010","article-title":"Splanchnic Nerve Block for Chronic Heart Failure","volume":"8","author":"Fudim","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacbts.2022.02.005","article-title":"Splanchnic Nerve Ablation for Volume Management in Heart Failure","volume":"7","author":"Fudim","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13054-016-1489-9","article-title":"Nomenclature for renal replacement therapy in acute kidney injury: Basic principles","volume":"20","author":"Neri","year":"2016","journal-title":"Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11886-012-0257-y","article-title":"Isolated ultrafiltration in heart failure patients","volume":"14","author":"Costanzo","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_30","unstructured":"Saunders, H., Rehan, A., Hashmi, M.F., and Sanghavi, D.K. (2024). Continuous Renal Replacement Therapy. StatPearls, StatPearls Publishing."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13054-022-03955-9","article-title":"Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: A secondary analysis of AKIKI and IDEAL-ICU studies","volume":"26","author":"Gaudry","year":"2022","journal-title":"Crit. Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/FJC.0b013e3181684026","article-title":"The effects of dobutamine on renal sympathetic activity in human heart failure","volume":"51","author":"Parker","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/j.jvca.2023.01.026","article-title":"Dispelling Dogma: Milrinone Therapy Is Safe and Effective in Renally-Impaired Patients, and We Knew This!","volume":"37","author":"Kumar","year":"2023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zucker, I.H., Xia, Z., and Wang, H.J. (2023). Potential Neuromodulation of the Cardio-Renal Syndrome. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030803"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, W.C., Lin, M.H., Chen, C.L., Lai, Y.C., Chen, C.Y., Lin, Y.C., and Hung, C.C. (2021). Comprehensive Comparison of the Effect of Inotropes on Cardiorenal Syndrome in Patients with Advanced Heart Failure: A Network Meta-Analysis of Randomized Controlled Trials. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184120"},{"key":"ref_36","unstructured":"(2024, November 01). Available online: https:\/\/www.nutritioncare.org\/Guidelines_and_Clinical_Resources\/Enteral_Nutrition_Resources\/."},{"key":"ref_37","unstructured":"(2024, November 01). Available online: https:\/\/trial2cure.com\/trialsindex.php?study=reducing-fluid-overload-in-heart-failure-patients-using-a-non-invasive-renal-independent-system."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ki.2012.406","article-title":"The relevance of congestion in the cardio-renal syndrome","volume":"83","author":"Gnanaraj","year":"2013","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacbts.2023.02.010","article-title":"Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure","volume":"8","author":"Biegus","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e009842","DOI":"10.1161\/CIRCHEARTFAILURE.122.009842","article-title":"Continuous-Flow Intra-Aortic Percutaneous Mechanical Circulatory Support in Heart Failure With Worsening Renal Function","volume":"16","author":"Grafton","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jchf.2023.06.018","article-title":"Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome","volume":"11","author":"Cowger","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_42","first-page":"100449","article-title":"First-in-Human Experience With the ModulHeart Device for Mechanical Circulatory Support and Renal Perfusion","volume":"1","author":"Georges","year":"2022","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5049\/EBP.2013.11.1.17","article-title":"Pharmacologic Management of the Cardio-renal Syndrome","volume":"11","author":"Kim","year":"2013","journal-title":"Electrolyte Blood Press"},{"key":"ref_44","first-page":"101210","article-title":"Emerging Device Therapies for Cardiorenal Syndrome","volume":"2","author":"Nathan","year":"2023","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cardfail.2012.10.010","article-title":"Congestive Renal Failure: The Pathophysiology and Treatment of Renal Venous Hypertension","volume":"18","author":"Ross","year":"2012","journal-title":"J. Card. Fail."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: The role of endothelial dysfunction and inflammation","volume":"18","author":"Damman","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.04.090","article-title":"Lymphatic Dysregulation in Patients With Heart Failure","volume":"78","author":"Fudim","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"Si","DOI":"10.1111\/j.1751-7133.2010.00176.x","article-title":"Volume overload and cardiorenal syndromes","volume":"16","author":"Ronco","year":"2010","journal-title":"Congest. Heart Fail."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1152\/ajpregu.00229.2023","article-title":"Short-term dynamic characteristics of diuresis during exogenous pressure perturbations with and without arterial baroreflex control","volume":"326","author":"Kawada","year":"2024","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjhf\/hfr070","article-title":"Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes","volume":"13","author":"Testani","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1517\/14656566.2012.749859","article-title":"Inotropes for the management of acute heart failure patients with renal dysfunction. Still an option?","volume":"13","author":"Parissis","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/eurjhf\/hft060","article-title":"Venous congestion and renal function in heart failure\u2026 it\u2019s complicated","volume":"15","author":"Testani","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/eurjhf\/hfq195","article-title":"Central venous pressure and impaired renal function in patients with acute heart failure","volume":"13","author":"Uthoff","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14797\/mdcvj.1121","article-title":"The Kidney in Heart Failure: The Role of Venous Congestion","volume":"18","author":"Ibrahim","year":"2022","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.12-1901","article-title":"Hemodynamic monitoring","volume":"143","author":"Hollenberg","year":"2013","journal-title":"Chest"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jacbts.2022.02.013","article-title":"Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure","volume":"7","author":"Dierckx","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11897-009-0016-6","article-title":"Pharmacologic management of the cardiorenal syndrome in heart failure","volume":"6","author":"Krum","year":"2009","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ackd.2018.08.006","article-title":"Pathophysiological Mechanisms in Cardiorenal Syndrome","volume":"25","author":"Rangaswami","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal Syndrome Revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.17219\/acem\/144327","article-title":"Cardiorenal syndrome: Decongestion in heart failure across wide spectrum of kidney pathophysiology","volume":"31","author":"Kosiorek","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/hearts5030024","article-title":"Strategies for the Management of Cardiorenal Syndrome in the Acute Hospital Setting","volume":"5","author":"Chandramohan","year":"2024","journal-title":"Hearts"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2018.09.085","article-title":"Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP)","volume":"275","author":"Keeble","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MAT.0000000000001498","article-title":"First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome","volume":"68","author":"Napp","year":"2022","journal-title":"Asaio. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacbts.2022.03.001","article-title":"Wireless Powered and Water-Proof Mechanical Circulatory Support Device for Ambulatory Class III Heart Failure","volume":"7","author":"Miller","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Fowler, J.W.M., Song, L., Tam, K., and Roth Flach, R.J. (2024). Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: Preclinical methods to analyze lymphatic function and therapeutic opportunities. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1412857"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacbts.2023.01.008","article-title":"Cardiac Lymphatic Insufficiency Leads to Diastolic Dysfunction Via Myocardial Morphologic Change","volume":"8","author":"Pu","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacbts.2021.09.008","article-title":"Direct Interstitial Decongestion in an Animal Model of Acute-on-Chronic Ischemic Heart Failure","volume":"6","author":"Abraham","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCRESAHA.122.321671","article-title":"Intestinal Lymphatic Dysfunction in Kidney Disease","volume":"132","author":"Zhong","year":"2023","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jchf.2023.06.021","article-title":"Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices","volume":"11","author":"Martens","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_72","unstructured":"(2014, November 15). Available online: https:\/\/whiteswell.com\/whiteswell-announces-six-month-outcomes-after-elym-system-treatment-for-acute-decompensated-heart-failure-patients-in-its-delta-hf-study\/."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e009787","DOI":"10.1161\/CIRCHEARTFAILURE.122.009787","article-title":"Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure","volume":"16","author":"Aronson","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ejhf.1533","article-title":"Controlled decongestion by Reprieve therapy in acute heart failure: Results of the TARGET-1 and TARGET-2 studies","volume":"21","author":"Biegus","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ejhf.3196","article-title":"Serial direct sodium removal in patients with heart failure and diuretic resistance","volume":"26","author":"Rao","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13089-024-00396-z","article-title":"Decoding VExUS: A practical guide for excelling in point-of-care ultrasound assessment of venous congestion","volume":"16","author":"Assavapokee","year":"2024","journal-title":"Ultrasound J."},{"key":"ref_77","first-page":"S218","article-title":"Utility of VExUS score in the peri-operative care unit, intensive care unit, and emergency setting\u2014A systematic review","volume":"67","author":"Gupta","year":"2023","journal-title":"Indian J. Anaesth."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7814\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:57:12Z","timestamp":1760115432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":77,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247814"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247814","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}